Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cerebrospinal Fluid Restores Vision

01.11.2004


A new method for visual impairment treatment has been discovered by researchers of the Institute of Human Brain, Russian Academy of Sciences. The patients suffering from visual impairment can be helped if a healthy donor’s cerebrospinal fluid is introduced to the parent’s vertebral canal – this method is called liquortransfusion. Physiologists have determined that the method is effective even when prescription of visual impairment exceeds five years. Eyesight improves with 83 percent of patients.



The reasons that deprive people of the ability for normal vision are multifarious – these are not only eye diseases, but also lesions of optic nerve, visual tracts and visual centers in the cerebrum. Till recently, physicians believed that effective treatment of visual system was possible only at early stages when no more than three months elapsed since the onset. Treatment at later stages was normally unsuccessful. Now physicians have the opportunity to restore vision of the patients who suffered visual impairment five and more years ago.

The method of endolumbal introduction (into the vertebral canal) of a healthy donor’s cerebrospinal fluid has been applied for several years already by specialists of the Institute of Human Brain, Russian Academy of Sciences. They have taken out a patent of the Russian Federation for application of this method for treatment of heavy neurologic patients who lost the ability for normal seeing. The donors are healthy volunteers, usually relatives of the patients. The cerebrospinal fluid (liquor) is transfused either immediately after it is taken from the donor or after short-term conservation and sterilization. Likewise blood transfusion, the group should be taken into account – the researchers have discovered four groups of cerebrospinal fluid (liquor) similar to four groups of blood.


Specialists state that one transfusion is sufficient to improve vision, in some cases the transfusion is repeated in several months. Vision is effectively restored with 83 percent of patients within the first two years after the disease onset, and at later stages - in 67.5 percent of cases. The researchers emphasize that treatment effectiveness does not significantly depend on the cause of the disease. The majority of patients experience vision improvement within the first two weeks after the procedure. Later on, vision rate continues to improve. Regardless of the visual system lesions degree, the general treatment response consists in expanding the field of vision. Even in case of amaurosis or if only light sensitivity is retained, it is possible to restore the outline vision and even subject vision after the cerebrospinal fluid (liquor) has been transfused.

The researchers explain the medicinaleffect of the donor cerebrospinal fluid by the presence of the substances similar to drugs in it – i.e., neuropeptides, which impact positively the systems of neural and neurohumoral regulation of the patient’s brain. These substances cause plastic rearrangements in the unaffected parts of the brain, and change interaction of various celebral structures that ensure visual functions. That allows the brain to make up the existing defects.

Clinical observations have proved that the cerebrospinal fluid (liquor) transfusion promotes electric cerebral biocurrents and initiates reorganization processes in the visual zone of the cerebral cortex and in the central nervous system as a whole. Neurohumoral regulation is evident in the fact that previously formed pathological relationship between cerebral portions gets suppressed and new relationship originates, which enables the visual system to function normally.

Sergey Komarov | alfa
Further information:
http://www.informnauka.ru

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>